Learning Objectives and Assessment Methodologies Combined Medicine-Pediatrics Rheumatology Elective
|
|
- Ann Owen
- 6 years ago
- Views:
Transcription
1 Learning Objectives and Assessment Methodologies Combined Medicine-Pediatrics Rheumatology Elective Overview: Med-Peds PGY2 s, PGY3 s and PGY4 s can elect to spend one four-week rotation with the adult and pediatric rheumatology units. Residents will spend two half-days each week in the Pediatric Rheumatology Clinics, two half-days in the month in the allergy clinic, two halfdays per week in their own continuity clinic, and the remainder of the time in the adult rheumatology clinic. Supervision of the residents will be by full-time faculty in our division of Pediatric Rheumatology and Immunology and in the division of Allergy/Immunology and Rheumatology. Residents will preferentially perform initial evaluations of adult and pediatric patients presenting with undifferentiated musculoskeletal complaints. Optimally, the resident will perform the initial evaluation, and see the patient back in follow up as often as possible to follow the results of their diagnostic and therapeutic interventions. Each patient is presented to a Rheumatology attending who then sees the patient to verify history and physical findings. The Med-Peds resident and Rheumatology, Allergy, or Immunology attending together develop a diagnostic and therapeutic plan. The Med-Peds resident will be responsible for documenting the visits and for understanding the correspondence with the patients referring physicians. It is the mission of this elective to provide residents a solid foundation in rheumatology, allergy, and immunology. This will train them to be physicians who will approach the patient with musculoskeletal, allergic, and immunologic complaints in an organized, efficient and professional manner; who will continue life-long learning in the subspecialties of rheumatology, allergy, and immunology which will enhance their knowledge base; and will enhance their communication and interpersonal skills as they relate to the subspecialties. Principle Teaching/Learning Activities: The principle teaching and learning activity during the Med-Peds Rheumatology elective is direct patient care activity working one-on-one with the Rheumatology attending staff. Med-Peds residents are expected to perform the appropriate procedures on their patients under the supervision of the Rheumatology attending or credentialed Rheumatology fellows; these procedures may include: joint aspiration and injection, microscopic examination of joint fluid, manipulation and injection of soft tissue pathology, and allergy testing and injections. Once during their rotation, the Med-Peds resident will present a one-hour talk to the Rheumatology faculty and fellows during the weekly Rheumatology conference, and they will attend all principle teaching conferences within the Rheumatology division. Their principle site of activity will be the ambulatory clinics as described above, but inpatient consultations
2 may be an additional learning opportunity as long as they do not significantly interfere with the ambulatory clinic sessions. by Relevant Competency In the tables below, the principle educational goals for the Combined Med-Peds Rheumatology Rotation are listed for each of the six ACGME competencies. The second column of the table indicates the most relevant assessment methods used to ensure that each resident achieves the educational objectives of each goal. 1) Patient Care by Level Each resident will efficiently perform a detailed history and examination of the musculoskeletal and immune systems. Each resident will formulate an appropriate differential diagnosis and efficient plan for the initial evaluation and management of patients with musculoskeletal and allergy complaints. Each resident will list the indications, contra-indications, and perform competently the procedures of joint aspiration, joint injection, and synovial fluid analysis. Direct Faculty 2) Medical Knowledge Each resident will describe the diagnostic criteria and natural history of rheumatoid arthritis, osteoarthritis, crystal induced arthritis, systemic lupus erythematosus, seronetative spondyloarthropathies, fibromyalgia, septic arthritis, Dermatomyositis, Systemic Lupus Erythematous, Scleroderma/Morphea, Acute Rheumatic Fever, Patellofemoral Pain Syndrome, Hypermobility Syndrome, Kawasaki s Disease, Toxic Synovitis of the Hip, Henoch Schonlein Purpura, Mixed Connective Tissue/Undifferentiated Connective Tissue Disease, and Musculoskeletal Pain without Inflammation Each resident will be able to recite the indications and side effects of the commonly used agents such as NSAIDs, hydroxychloroquine, sulfasalazine, minocycline, Participation and Presentation at weekly Rheumatology conference Patient case log
3 methotrexate, azathioprine, cyclophosphamide, etanercept, infliximab, leflunomide, corticosteroids, colchicine, probenecid, allopurinol, inhaled steroids, immunotherapy, leukotriene inhibitors, antihistamines, H2 blockers, adalimumab, anakinra, and monoclonal Ab to IgE. Each resident will recognize the key radiographic features of rheumatoid arthritis, osteoarthritis, gout, pseudogout, and seronegative spondyloarthropathies. Participation and presentation at weekly Rheumatology conference 3) Practice-Based Learning and Improvement Each resident will be able to identify and acknowledge gaps in personal knowledge and skills in the care of patients with musculoskelatal and allergic complaints Each resident will be able to list useful sources to fill knowledge gaps about musculoskeletal and allergic complaints and problems. Reading log 4) Interpersonal Skills and Communication Each resident will be able to clearly and succinctly present patient information, both verbally and in writing, and discuss patient information with referring physicians. Direct Faculty Chart Review Each resident will communicate clearly, compassionately, and sensitively with patients and their families around complex rheumatologic and allergic issues. Periodic Patient Evaluation of Resident
4 5) Professionalism Each resident will demonstrate sensitivity and responsiveness to the unique personal and cultural situation of each patient, and provide care respecting each patient s personal values and goals, taking into consideration their developmental stage. Each resident will demonstrate respect, compassion, integrity, and altruism in relationships with patients, families, and colleagues in all health professions. Each resident will behave professionally and ethically toward towards patients, families, colleagues, and all members of the health care team. Periodic Patient Evaluation of Resident Periodic Patient, Staff, and Nursing Evaluation of Resident Periodic Patient, Staff, and Nursing Evaluation of Resident 6) Systems-Based Practice Each resident will understand and utilize the multidisciplinary resources necessary to care optimally for patients with rheumatologic and allergic issues, including support groups. Each resident will be able to collaborate with other members of the health care team to assure comprehensive care for patients with rheumaologic and allergic issues. Each resident will be able to assist their patients in negotiating the health care system complexities. Direct Faculty Global Peer Assessment Direct Faculty
5 Each resident will be able to use evidence-based, costconscious strategies in the care of patients with rheumatologic and allergic issues. Periodic Patient Evaluations Direct Faculty Recommended Resources Cassidy JT, Petty RE, Textbook of Pediatric Rheumatology (Fourth Edition). Philadelphia: W.B. Saunders, Reprints specific to patient issues are also provided to residents Primer for Rheumatologic Diseases Evaluation Methods Residents are formally evaluated by the Rheumatology Attendings and Fellows, patients, nurses, and staff at the end of the rotation using the standard evaluation forms used by the Internal Medicine-Pediatrics Residency for all residents.
Lahey Clinic Internal Medicine Residency Program: Curriculum for Rheumatology
Lahey Clinic Internal Medicine Residency Program: Curriculum for Rheumatology Faculty representative: Chris Kovacs, MD, MPH Resident representative: Diane Hislop, MD Revision date: February 1, 2006 Overview
More informationSCOPE OF PRACTICE PGY-4 PGY-5
PGY-4 Examine in a timely fashion inpatients and outpatients, including ER visits, for which rheumatology consultation is requested. Prepare a thorough summary of clinical, serologic and radiographic findings
More informationRheumatology Residency Rotation University of Colorado Health Sciences Center
2010 Rheumatology Residency Rotation University of Colorado Health Sciences Center This paragraph only applies if you are rotating at the University of Colorado Hospital. Please review the rest of the
More informationRHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center
RHEUMATOLOGY OVERVIEW Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center What is Rheumatology? Medical science devoted to the rheumatic diseases
More informationCompetency Based Curriculum
Competency Based Curriculum Internal Medicine Residency Program The George Washington University Curriculum last updated on: 04/29/2009 Rotation: Division: Site: Director: Rheumatology Division of Rheumatology
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abatacept, for rheumatoid arthritis, 789 Acetaminophen, for low back pain, 735 Acupuncture for fibromyalgia, 753 for low back pain, 738
More informationKelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition
Kelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition Firestein, G ISBN-13: 9781437717389 Table of Contents VOLUME I STRUCTURE AND FUNCTION OF BONE,
More informationProposed Retirement for HEDIS : Disease-Modifying Anti-Rheumatic Drug Therapy for Rheumatoid Arthritis (ART)
Proposed Retirement for HEDIS 1 2020 2 : Disease-Modifying Anti-Rheumatic Drug Therapy for Rheumatoid Arthritis (ART) NCQA seeks public comment on the proposed retirement of the Disease-Modifying Anti-Rheumatic
More information10 Musculoskeletal and Joint Diseases
10 Musculoskeletal and Joint Diseases To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and British Society of Rheumatology guidelines and guidance
More informationHelpline No:
ARTHRITIS FOUNDATION Registered Nonprofit Organisation - No. 002-847 NPO Helpline No: 0861 30 30 30 DRUGS AND ARTHRITIS This information leaflet is published by the Arthritis Foundation as part of our
More informationRheumatology Educational Goals & Objectives
Rheumatology Educational Goals & Objectives Musculoskeletal complaints are very common in the practice of primary care. They may reflect overuse or trauma, or be a manifestation of a broad range of musculoskeletal
More informationRheumatoid Arthritis
Rheumatoid Arthritis What is rheumatoid arthritis? Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints. Rheumatoid arthritis can also cause inflammation of
More informationPatient #1. Rheumatoid Arthritis. Rheumatoid Arthritis. 45 y/o female Morning stiffness in her joints >1 hour
Patient #1 Rheumatoid Arthritis Essentials For The Family Medicine Physician 45 y/o female Morning stiffness in her joints >1 hour Hands, Wrists, Knees, Ankles, Feet Polyarticular, symmetrical swelling
More informationUniversity of Nebraska Medical Center Rheumatology Fellowship. Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun R/S R/S R/S R/S
University of Nebraska Medical enter Rheumatology Fellowship This fellowship is meant to be a mix of clinical and research experience. We have a rich didactic experience, with extra focus on Musculoskeletal
More informationMSK Module 15 CBC Orthopaedic Surgery. Medical Expert & Scholar Objectives General
MSK Module 15 CBC Orthopaedic Surgery Medical Expert & Scholar Objectives General The following competencies will assist in satisfying the CanMeds objectives for medical expert including scholarship. It
More informationCoverage Criteria: Express Scripts, Inc. monograph dated 12/15/ months or as otherwise noted by indication
BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Kineret (anakinra subcutaneous injection) Commercial HMO/PPO/CDHP
More informationVersion 06/09/2017 RHEUMATOLOGY FELLOWSHIP CURRICULUM OREGON HEALTH AND SCIENCE UNIVERSITY
RHEUMATOLOGY FELLOWSHIP CURRICULUM OREGON HEALTH AND SCIENCE UNIVERSITY I. Mission The subspecialty of rheumatology includes evaluation and treatment of a wide array of inflammatory, non-inflammatory,
More information2017 PERIOPERATIVE MEDICINE SYMPOSIUM Peri-operative use of immunosuppression in rheumatology patients
2017 PERIOPERATIVE MEDICINE SYMPOSIUM Peri-operative use of immunosuppression in rheumatology patients Dr Alberta Hoi Rheumatologist MBBS, FRACP, PhD NEW ERA IN MUSCULOSKELETAL MEDICINE New drugs - Biologics,
More informationThe Hospital for Sick Children Technology Assessment at SickKids (TASK)
The Hospital for Sick Children Technology Assessment at SickKids (TASK) THE USE OF BIOLOGIC RESPONSE MODIFIERS IN POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS Report No. 2010-01 Date: January 11,
More informationLOCALLY AVAILABLE BIOLOGIC AGENTS IN THE TREATMENT OF PSORIATIC ARTHRITIS
Locally Available Biologic Agents in the Treatment of Psoriatic Arthritis 253 Phil. J. Internal Medicine, 47: 253-259, Nov.-Dec., 2009 LOCALLY AVAILABLE BIOLOGIC AGENTS IN THE TREATMENT OF PSORIATIC ARTHRITIS
More informationRHEUMATOLOGY EDUCATION IN UNITED STATES MEDICAL SCHOOLS
1561 - SPECIAL ARTICLE.- ~ RHEUMATOLOGY EDUCATION IN UNITED STATES MEDICAL SCHOOLS DON L. GOLDENBERG, JOHN H. MASON, RAPHAEL DE HORATIUS, VICTOR GOLDBERG, STEPHEN R. KAPLAN, HAROLD KEISER, MICHAEL D. LOCKSHIN,
More informationCurricular Components for Rheumatology EPA
Curricular Components for Rheumatology EPA 1. EPA Title Manage patients with acute or chronic complex multi-system rheumatic disease in an ambulatory, emergency, or inpatient setting. 2. Description of
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: golimumab_simponi 8/2013 2/2018 2/2019 3/2018 Description of Procedure or Service Golimumab (Simponi and
More informationAdvanced Drug Allergy Fellowship at the McGill University
Centre universitaire de santé McGill McGill University Health Centre Les meilleurs soins pour la vie The Best Care for Life Type of Fellowship: Clinical and Clinical Research Number of Fellowship positions:
More informationJuvenileIdiopathicArthritis. Dr Johan Siebert
JuvenileIdiopathicArthritis Dr Johan Siebert 1 NORMAL DIARTHRODIAL JOINT Synovial is a thin membrane enclosing the joint space The joint space contains fluid that bathes the joint and reduces friction
More informationRHEUMATOLOGY TRAINING AT INTERNAL MEDICINE AND FAMILY PRACTICE RESIDENCY PROGRAMS
47 1 SPECIAL ARTICLE RHEUMATOLOGY TRAINING AT INTERNAL MEDICINE AND FAMILY PRACTICE RESIDENCY PROGRAMS DON L. GOLDENBERG, RAPHAEL J. DEHORATIUS, STEPHEN R. KAPLAN, JOHN MASON, ROBERT MEENAN, SUSAN G. PERLMAN,
More informationEssential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT
Essential Rheumatology Dr Ellen Bruce Consultant Rheumatologist CMFT Saving the best for last! Apparently people recall best the first and last thing they re told. Far too difficult to include everything.
More informationRegulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of: (2-3)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.51 Subject: Simponi / Simponi ARIA Page: 1 of 9 Last Review Date: March 16, 2018 Simponi / Simponi
More informationThe diagnostic challenge of joint pain part 2
Musculoskeletal 407 The diagnostic challenge of joint pain part 2 Polyarthralgia is a common presentation in primary care. Because chronic arthritides may present abruptly, they need to be considered in
More informationLAC-USC Cardiology Consult Service
LAC-USC Cardiology Consult Service RESIDENT ORIENTATION First Day of Rotation: Report to 1 st day at LAC + USC Hospital 4 th floor Cardiology units Page Fellow day before rotation for more information
More information2017 BlueCare Plus (HMO SNP) SM Stars Quality Attestation Form
2017 BlueCare Plus (HMO SNP) SM Stars Quality Attestation Form Provider Name Contract Entity/Group Name Patient Preventive Screenings Breast Cancer Screening Colorectal Cancer Screening The Breast Cancer
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: abatacept_orencia 4/2008 2/2018 2/2019 2/2018 Description of Procedure or Service Abatacept (Orencia ), a
More informationAnalgesics. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine The University of Jordan March, 2014
Analgesics Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine The University of Jordan March, 2014 Mar-14 Munir Gharaibeh, MD, PhD, MHPE 2 Feature Comparison of Analgesics Narcotic (Opioids) Nonnarcotic
More informationDUKE INTERNAL MEDICINE RESIDENCY PROGRAM NEUROLOGY CONSULTS ROTATION DESCRIPTION.
Department of Medicine Internal Medicine Residency Program DUKE INTERNAL MEDICINE RESIDENCY PROGRAM NEUROLOGY CONSULTS ROTATION DESCRIPTION http://neurology.medicine.duke.edu/ ROTATION DIRECTOR: Saurabh
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abatacept, 239 Acetaminophen, 194 Acupuncture, 205 Adalimumab, 187, 226, 239, 247 Allopurinol, for gout, 188 American College of Rheumatology,
More information1 P a g e. Systemic Juvenile Idiopathic Arthritis (SJIA) (1.3) Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.
LENGTH OF AUTHORIZATION: Initial: 3 months for Crohn s or Ulcerative Colitis; 1 year for all other indications. Renewal: 1 year dependent upon medical records supporting response to therapy and review
More informationEffective Health Care Program
Comparative Effectiveness Review Number 28 Effective Health Care Program Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) Executive Summary Background
More informationMEDICINE/PEDIATRICS PROGRAM CURRICULUM OVERVIEW. A = Ambulatory I = Inpatient C = Combined
MEDICINE/PEDIATRICS PROGRAM CURRICULUM OVERVIEW A = Ambulatory I = Inpatient C = Combined INTERNAL MEDICINE PEDIATRICS R-1 Rotations Months Type R-1 Rotations Months Type General Medicine Inpatient 2 I
More informationRHEUMATOID ARTHRITIS DRUGS
Rheumatology Biologics Criteria from the Exceptional Access Program RHEUMATOID ARTHRITIS DRUGS DRUG NAME BRS REIMBURSED DOSAGE FORM/ STRENGTH Adalimumab Humira 40 mg/0.8 syringe and 40mg/0.8 pen for Anakinra
More informationPharmacological Management of Knee Pain
Pharmacological Management of Knee Pain Dr Indi Rasaratnam Consultant Rheumatologist, Epworth Health Care & The Alfred Senior Lecturer, Department of Medicine, Monash University Outline of Presentation
More informationC. Assess clinical response after the first three months of treatment.
Government Health Plan (GHP) of Puerto Rico Authorization Criteria Tumor Necrosis Factor Alpha (TNFα) Adalimumab (Humira ) Managed by MCO Section I. Prior Authorization Criteria A. Physician must submit
More informationPerioperative Medicine:
Perioperative Medicine: Management of rheumatologic agents Divya Gollapudi, MD May 2016 Medical Operative Consult Clinic Harborview Medical Center Your patient Ms. L is a 55 year-old F w/ h/o RA who presents
More informationp. 70 p. 94 p. 102 p. 105 p. 108
European League Against Rheumatism EULAR - a vehicle for communication p. 3 EULAR - a vehicle for communication; the role of ILAR p. 8 Overview on the Scientific Basis of Rheumatic Diseases Molecular and
More informationErelzi (etanercept) Frequently Asked Questions
Erelzi (etanercept) Frequently Asked Questions 1. What is the funding status of Erelzi (etanercept)? Effective December 21, 2017, Erelzi (etanercept) will be added to the Ontario Drug Benefit (ODB) Formulary
More informationStep Therapy Approval Criteria
Effective Date: 10/01/2016 This document contains Step Therapy Approval Criteria for the following medications: 1. Colcrys (colchicine) 2. Cymbalta (duloxetine) 3. Dovonex (calcipotriene) 4. Enbrel (etanercept)
More informationPain or stiffness in joints after periods of inactivity or excessive use
Arthritis Awareness* Some older adults call it Arthur ; others refer to it as their constant compassion, but most describe it as extremely painful Arthritis is a chronic joint disease It is commonly believed
More informationDEPARTMENT OF RHEUMATOLOGY
DEPARTMENT OF RHEUMATOLOGY PG Teaching Schedule Theory (8 30 am to 9am) DATE TOPIC PRESENTER FACULTY 01/10/16 Approach to Arthritis Dr. Sandeep Dr. Suma Balan 03/10/16 Cardiovascular risk in Rheumatic
More informationRheumatoid Arthritis. By: Hadi Esmaily (PharmD., BCCP, MBA) Department of Clinical Pharmacy, Shahid Beheshti Medical University
Rheumatoid Arthritis By: Hadi Esmaily (PharmD., BCCP, MBA) Department of Clinical Pharmacy, Shahid Beheshti Medical University Introduction RA is a Chronic, Systemic, Inflammatory disorder of unknown etiology
More informationHofstra Northwell School of Medicine Department of Neurology Epilepsy Fellowship Program. Skills and Competencies Rotation Goals and Objectives
Hofstra Northwell School of Medicine Department of Neurology Epilepsy Fellowship Program Skills and Competencies Rotation Goals and Objectives The purpose of the Epilepsy fellowship program is to provide
More informationNational Institute for Health and Clinical Excellence SCOPE. Rheumatoid arthritis: the management and treatment of rheumatoid arthritis in adults
National Institute for Health and Clinical Excellence 1 Guideline title SCOPE Rheumatoid arthritis: the management and treatment of rheumatoid arthritis in adults 1.1 Short title Rheumatoid arthritis 2
More informationHEALTHCARE EFFECTIVENESS DATA AND INFORMATION SET (HEDIS )
STARS MEASURES 2015 HEALTHCARE EFFECTIVENESS DATA AND INFORMATION SET (HEDIS ) Developed by the National Committee for Quality Assurance (NCQA), HEDIS is the most widely used set of performance measures
More informationRheumatology Review Update in Internal Medicine COPYRIGHT. Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center.
Rheumatology Review Update in Internal Medicine Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center Boston MA Case #1 True statement(s) regarding etanercept and leflunomide, for the treatment
More informationCimzia. Cimzia (certolizumab pegol) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.11 Section: Prescription Drugs Effective Date: April 1, 2018 Subject: Cimzia Page: 1 of 5 Last Review
More informationUCSD DEPARTMENT OF ANESTHESIOLOGY
UCSD DEPARTMENT OF ANESTHESIOLOGY LEARNING OBJECTIVES FOR ADVANCED PAIN MEDICINE ROTATION, UCSD MEDICAL CENTER Competencies Objective Learning Environment Instructional Method Assessment Tool Patient Care:
More informationTreatment of Rheumatoid Arthritis: The Past, the Present and the Future
Treatment of Rheumatoid Arthritis: The Past, the Present and the Future Lai-Ling Winchow FCP(SA) Cert Rheum(SA) Chris Hani Baragwanath Academic Hospital University of the Witwatersrand Outline of presentation
More informationSeronegative Arthritis. Dr Mary Gayed 25 th April 2018
Seronegative Arthritis Dr Mary Gayed 25 th April 2018 Overview Description of the conditions Discussion of symptoms & investigations that may be required Discussion of management and treatment Questions
More informationUnderstanding Arthritis. Training
Understanding Arthritis Training 1 Learning Objectives At the end of this training the learner will: Be able to define Arthritis Describe the symptoms of Arthritis Understand the impact of Arthritis Know
More informationPHARMACY POLICY STATEMENT Ohio Medicaid
DRUG NAME BILLING CODE BENEFIT TYPE SITE OF SERVICE ALLOWED COVERAGE REQUIREMENTS LIST OF DIAGNOSES CONSIDERED NOT MEDICALLY NECESSARY PHARMACY POLICY STATEMENT Ohio Medicaid Enbrel (etanercept) Must use
More informationMusculoskeletal Tumor Society Curriculum Guidelines for Clinical Fellowship Programs In Musculoskeletal Oncology
Musculoskeletal Tumor Society Curriculum Guidelines for Clinical Fellowship Programs In Musculoskeletal Oncology Preamble: The Musculoskeletal Tumor Society (MSTS) is committed to excellence in the fellowship
More informationCURRICULUM on PGY2 AMBULATORY CARE ROTATION UC Davis Internal Medicine Residency Program
CURRICULUM on PGY2 AMBULATORY CARE ROTATION UC Davis Internal Medicine Residency Program Lead Faculty Members: Darin Latimore, MD Tonya Fancher, MD MPH I. Educational Purpose and Goals By the end of this
More informationInformation for Residents Rotating in Allergy/Clinical Immunology. Welcome to your rotation in Allergy/Clinical Immunology. Enclosed you will find:
Information for Residents Rotating in Allergy/Clinical Immunology Welcome to your rotation in Allergy/Clinical Immunology. Enclosed you will find: 1. Rotation specific objectives. 2. Transcription requirements.
More informationHAQ-II(Health Assessment Questionnaire-II)
Kathy Karamlou, MD 355 Placentia Ave, suite 208 Newport Beach, CA 92663 949-631-6500 949-631-9700 NAME: DATE: DOB: HAQ-II(Health Assessment Questionnaire-II) We are interested in learning how your illness
More informationSpeaker 1 Affiliation. Speaker 2 Affiliation. Speaker 3 Affiliation
RHEUMATOLOGY AND MUSCULOSKELETALL MEDICINE FOR PRIMARY CARE New York, New York InterContinental New York Times Square April 25 27,, 2014 Participating Faculty Speaker 1 Affiliation Speaker 2 Affiliation
More informationDRUG THERAPY
www.pediatric-rheumathology.printo.it DRUG THERAPY NSAIDS NON-STEROIDAL ANTI-INFLAMMATORY DRUGS They are symptomatic anti-inflammatory, anti febrile (fever) and analgesic (pain reducing) medications. Symptomatic
More informationSalicylates: Interactions 10/14/2009. Salicylates DRUGS USED IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS. Chapters 17, 18, 34 & Pages 577 &
DRUGS USED IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS Chapters 17, 18, 34 & Pages 577 & 579-586 Salicylates aspirin Have analgesic, antipyretic, and anti-inflammatory effects. Inhibits the production
More informationBIOLOGIC THERAPY : A NEW OPTION FOR TREATMENT JUVENILE IDIOPATHIC ARTHRITIS DR TON THAT HOANG
BIOLOGIC THERAPY : A NEW OPTION FOR TREATMENT JUVENILE IDIOPATHIC ARTHRITIS DR TON THAT HOANG INTRODUCTION JIA is the most common chronic rheumatic inflammatory disease of childhood. If not successfully
More informationRheumatology Therapeutics: Perioperative DMARD Management, Infection and Malignancy Risks, Vaccination Considerations. Heather Hansen, MD
Rheumatology Therapeutics: Perioperative DMARD Management, Infection and Malignancy Risks, Vaccination Considerations Heather Hansen, MD Objectives Know Broad Categories of Rheumatoid Arthritis Medications
More informationPATHOLOGY FELLOWSHIP PROGRAM IN LYMPHOPROLIFERATIVE DISORDERS
PATHOLOGY FELLOWSHIP PROGRAM IN LYMPHOPROLIFERATIVE DISORDERS The Department of Pathology and Laboratory Medicine University of Alberta, Faculty of Medicine and Dentistry and Alberta Health Services PATHOLOGY
More informationClinical Policy: Etanercept (Enbrel) Reference Number: PA.CP.PHAR.250 Effective Date: 01/18 Last Review Date: 08/17 Line of Business: Medicaid
Clinical Policy: (Enbrel) Reference Number: PA.CP.PHAR.250 Effective Date: 01/18 Last Review Date: 08/17 Line of Business: Medicaid Coding Implications Revision Log Description (Enbrel ) is tumor necrosis
More information1. Background: Infliximab is administered parenterally; therefore, it is not covered under retail pharmacy benefits.
Subject: Infliximab (Remicade ) Original Original Committee Approval: October 13, 2006 Revised Last Committee Approval: December 3, 2008 Last Review: October 19, 2007 1. Background: Infliximab is a genetically
More informationPGY-1 Orthopaedic Surgery Rotation Family Medicine Faculty Liaison: P. M. Lundblad, MD Last reviewed/update: 4/2017
PGY-1 Orthopaedic Surgery Family Medicine Faculty Liaison: P. M. Lundblad, MD Last reviewed/update: 4/2017 The Orthopaedic Surgery rotation is a required 4-week block experience completed during the PGY-1
More informationCurriculum: Goals and Objectives Department of Medicine Harbor-UCLA Medical Center
MEDICAL ONCOLOGY AND HEMATOLOGY (R2, R3) A. The PURPOSE of this rotation is to afford medical residents a broad clinical and training experience in the clinical diagnosis and management of common adult
More informationAd-Hoc Rheumatology Subcommittee of PTAC meeting held 8 March. (minutes for web publishing)
Ad-Hoc Rheumatology Subcommittee of PTAC meeting held 8 March 2011 (minutes for web publishing) Ad-Hoc Rheumatology Subcommittee minutes are published in accordance with the Terms of Reference for the
More informationSubject: Remicade (Page 1 of 5)
Subject: Remicade (Page 1 of 5) Objective: I. To ensure that Health Share/Tuality Health Alliance (THA) has a process by which the appropriate utilization of Remicade (Infliximab) for members whose diagnosis
More informationBasic Standards for Fellowship Training in Sleep Medicine
Basic Standards for Fellowship Training in Sleep Medicine American Osteopathic Association and American College of Osteopathic Neurologists and Psychiatrists and American College of Osteopathic Internists
More informationBasic Standards for Residency/Fellowship Training in Geriatric Psychiatry
Basic Standards for Residency/Fellowship Training in Geriatric Psychiatry American Osteopathic Association and American College of Osteopathic Neurologists and Psychiatrists Approved 2/2005 Revised 2/2008,
More informationIs it Autoimmune or NOT! Presented to AONP! October 2015!
Is it Autoimmune or NOT! Presented to AONP! October 2015! Four main jobs of immune system Detects Contains and eliminates Self regulates Protects Innate Immune System! Epithelial cells, phagocytic cells
More informationALLERGY AND CLINICAL IMMUNOLOGY FELLOWSHIP PROGRAM DEPARTMENT OF PEDIATRICS
ALLERGY AND CLINICAL IMMUNOLOGY FELLOWSHIP PROGRAM DEPARTMENT OF PEDIATRICS I. INTRODUCTION The Pediatric Allergy and Immunology (A&I) Fellowship Program at King Faisal Specialist Hospital and Research
More informationSpondyloarthropathies: Disease Perception Limits Market
Spondyloarthropathies: Disease Perception Limits Market Psoriatic arthritis and ankylosing spondylitis form part of the group of diseases known as the spondyloarthropathies. Psoriatic arthritis is a form
More informationAnti-Tumor Necrosis Factor (Anti-TNF)
Anti-Tumor Necrosis Factor (Anti-TNF) 110465 Anti-TNF.indd 1 9/20/16 9:01 AM s About your medicine Anti-tumor necrosis factor (anti-tnf) is a type of medicine called biologic agent that targets substance
More informationImmune Modulating Drugs Prior Authorization Request Form
Patient: HPHC member ID #: Requesting provider: Phone: Servicing provider: Diagnosis: Contact for questions (name and phone #): Projected start and end date for requested Requesting provider NPI: Fax:
More informationCURRICULUM VITAE. Dallas, Texas 75204
CURRICULUM VITAE NAME: BUSINESS ADDRESS: HOME ADDRESS: Rachel Tate, DO Arthritis Care and Research Center Baylor Research Institute 9900 N Central Expressway Dallas, Texas 75231 (214) 373-4321 - Office
More informationJuvenile Chronic Arthritis
Juvenile Chronic Arthritis Dr. Christa Visser MBChB MMed (Med Phys) Diploma Musculoskeletal Medicine (UK), Member Society of Orthopaedic Medicine (UK) Childhood Arthritis JCA/JIA/JRA Remember Acute rheumatic
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES HUMIRA PEDIATRIC
Generic Brand HICL GCN Exception/Other ADALIMUMAB HUMIRA 24800 HUMIRA PEDIATRIC GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW) 1. Is the patient currently taking Humira? If
More information1. Discuss the basic pathophysiology of end-stage liver and kidney failure.
TRANSPLANT SURGERY ROTATION (PGY1, 2) A. Medical Knowledge Goal: The resident will achieve a detailed knowledge of the evaluation and treatment of a variety of disease processes. The resident will be exposed
More informationMedical Management of Rheumatoid Arthritis (RA)
Medical Management of Rheumatoid Arthritis (RA) Dr Lee-Suan Teh Rheumatologist Royal Blackburn Hospital Educational objectives ABC Appreciate the epidemiology of RA Be able to diagnosis of RA Competent
More informationWhat organ system is involved? What is the pathology? What is the possible etiology?
Johan van Rensburg What organ system is involved? What is the pathology? What is the possible etiology? Genetic Environmental What are the possible complications? How is the patient s functioning impaired?
More informationTable 61-5: Normal Physical Assessment of the Musculoskeletal System, p Table 61-1: Gerontologic Assessment Differences, p1451
Unit II: Activity and Rest Needs- Musculoskeletal System Los Angeles Harbor College Associate Degree Nursing Program Description: After appropriate study and practice, the nursing student will be able
More informationArthritis. that affects the joints.
Arthritis that affects the joints. The word arthritis literally means inflammation of the joints. Though joint inflammation is often a symptom, rather than a specific diagnosis itself, the term arthritis
More informationCELEBRATING 169 YEARS OF TRADITION AND TRANSFORMATION IN HEALTHCARE RESEARCH
CELEBRATING 169 YEARS OF TRADITION AND TRANSFORMATION IN HEALTHCARE RESEARCH Our MISSION Building on our tradition Reaching out to the community Doing our best to serve, care and heal Together, we aim
More informationADALIMUMAB Generic Brand HICL GCN Exception/Other ADALIMUMAB HUMIRA GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW)
Generic Brand HICL GCN Exception/Other ADALIMUMAB HUMIRA 24800 GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW) 1. Does the patient have a diagnosis of moderate to severe rheumatoid
More informationChallenges in Perioperative Medication Management. Learning Objectives. Case 1. » Appropriate use of beta-blockers. Management of diabetes drugs
Challenges in Perioperative Medication Management Dimitriy Levin, MD Assistant Professor of Medicine University of Colorado Hospital Medicine Group Learning Objectives» Appropriate use of beta-blockers
More informationUND GERIATRIC MEDICINE FELLOWSHIP CURRICULUM RESEARCH
CONTACTS: SUPERVISING FACULTY FOR THE BLOCK: Dr. Marilyn Klug marilyn.klug@und.edu Dr. Gunjan Manocha gunjan.dhawan@und.edu PROGRAM CONTACT: Dr. Gunjan Manocha gunjan.dhawan@und.edu Carla Mosser carla.mosser@und.edu
More informationClinical Policy: Certolizumab (Cimzia) Reference Number: PA.CP.PHAR.247 Effective Date: 01/18 Last Review Date: 08/17 Line of Business: Medicaid
Clinical Policy: (Cimzia) Reference Number: PA.CP.PHAR.247 Effective Date: 01/18 Last Review Date: 08/17 Line of Business: Medicaid Coding Implications Revision Log Description (Cimzia ) is a tumor necrosis
More informationTeaching Day in Rheumatic Diseases
Texas Heath Presbyterian Hospital Dallas Teaching Day in Rheumatic Diseases Saturday, October 1, 2016 8 a.m. - 3 p.m. Fogelson Forum Auditorium 8200 Walnut Hill Lane Dallas, TX 75231 TexasHealth.org/CME
More informationFinancial Report. Moving Together
Financial Report 2013 Moving Together Our Purpose To improve the quality of life of people who have, or are at risk of developing musculoskeletal conditions. Our Values Respect and integrity Service and
More informationTHERAPY in RHEUMATOLOGY
THERAPY in RHEUMATOLOGY RA OA AS Systemic diseases SLE Dermatomyositis Scleroderma Gout Rheumatic fever Lyme disease RHEUMATOID ARTRHRITIS Education Build a cooperative long-term relationship Use materials
More informationA. Correct! Nociceptors are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain.
Pharmacology - Problem Drill 19: Anti-Inflammatory and Analgesic Drugs No. 1 of 10 1. are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain. #01 (A) Nociceptors (B) Histamines
More information